We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

90 hedge funds and large institutions have $199M invested in BioSpecifics Technologies Corp. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

1% more funds holding

Funds holding: 89 → 90 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

22% less capital invested

Capital invested by funds: $255M → $199M (-$56.2M)

Holders
90
Holders Change
+1
Holders Change %
+1.12%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
34
Reduced
34
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$3.14M
2
Goldman Sachs
Goldman Sachs
New York
+$2.87M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.42M
4
RHJA
Rice Hall James & Associates
California
+$1.63M
5
Deutsche Bank
Deutsche Bank
Germany
+$1.48M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$2.74M
2
WCM
Wedge Capital Management
North Carolina
-$2.09M
3
GC
Globeflex Capital
California
-$1.82M
4
PI
Putnam Investments
Massachusetts
-$1.62M
5
FQ
First Quadrant
California
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$19.7M +$2.42M +46,173 +13%
BlackRock
2
BlackRock
New York
$18.9M +$221K +4,214 +1%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$13.2M +$972K +18,562 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.92M +$159K +3,030 +2%
EAM
5
Eagle Asset Management
Florida
$9.02M +$54.4K +1,039 +0.6%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$8.17M -$1.03M -19,666 -11%
RHJA
7
Rice Hall James & Associates
California
$8M +$1.63M +31,175 +24%
ECP
8
Elk Creek Partners
Colorado
$7.2M -$296K -5,657 -4%
Goldman Sachs
9
Goldman Sachs
New York
$5.59M +$2.87M +54,777 +94%
NC
10
Northpointe Capital
Michigan
$5.43M -$708K -13,508 -11%
State Street
11
State Street
Massachusetts
$4.97M +$590K +11,271 +13%
NI
12
Numeric Investors
Massachusetts
$4.75M -$2.74M -52,390 -35%
AQR Capital Management
13
AQR Capital Management
Connecticut
$4.57M +$951K +18,146 +24%
Allianz Asset Management
14
Allianz Asset Management
Germany
$4.19M +$944K +18,026 +27%
Northern Trust
15
Northern Trust
Illinois
$4.18M +$228K +4,351 +5%
JAM
16
JW Asset Management
Florida
$3.65M – – –
Wellington Management Group
17
Wellington Management Group
Massachusetts
$3.56M – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$3.37M +$33.7K +643 +1%
Prudential Financial
19
Prudential Financial
New Jersey
$3.25M +$17.2K +328 +0.5%
SCM
20
Stonepine Capital Management
Oregon
$2.96M +$3.14M +59,878 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.84M -$459K -8,756 -13%
MCM
22
Matarin Capital Management
New York
$2.82M -$118K -2,244 -4%
OAM
23
Oxford Asset Management
United Kingdom
$2.74M +$684K +13,054 +31%
Invesco
24
Invesco
Georgia
$2.62M -$129K -2,459 -4%
MOACM
25
Mutual of America Capital Management
New York
$2.62M -$96.8K -1,847 -3%
1
2 3 4

BSTC Hedge Fund Activity: Q2 2017 in Review

90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2017, worth a combined $199M — down 22% from $255M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BSTC positions and 6 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $3.14M. The largest seller was Numeric Investors, cutting an estimated $2.74M.

  • 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2017, up from 89 in Q1 2017.
  • Funds reported $199M of BioSpecifics Technologies Corp. stock for Q2 2017, down 22% quarter-over-quarter.
  • 7 funds opened new BioSpecifics Technologies Corp. positions in Q2 2017 and 6 closed out, a net change of +1 holder.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2017 was Stonepine Capital Management, an estimated $3.14M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2017 was Numeric Investors, an estimated $2.74M sold.

Based on aggregated 13F filings for Q2 2017.